Your browser doesn't support javascript.
loading
Immunogenicity and Safety of AS03-adjuvanted H5N1 Influenza Vaccine in Children 6-35 Months of Age: Results From a Phase 2, Randomized, Observer-blind, Multicenter, Dose-ranging Study.
Kim, Joon Hyung; Drame, Mamadou; Puthanakit, Thanyawee; Chiu, Nan-Chang; Supparatpinyo, Khuanchai; Huang, Li-Min; Chiu, Cheng-Hsun; Chen, Po-Yen; Hwang, Kao-Pin; Danier, Jasur; Friel, Damien; Salaun, Bruno; Woo, Wayne; Vaughn, David W; Innis, Bruce; Schuind, Anne.
Afiliação
  • Kim JH; From the Vaccines Clinical Research and Development, GSK, Rockville, Maryland.
  • Drame M; Vaccine Biostatistics Department, GSK, Rockville, Maryland.
  • Puthanakit T; Department of Pediatrics, Center of Excellence in Pediatric Infectious Diseases and Vaccines, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Chiu NC; Department of Pediatrics, Mackay Children's Hospital, Taipei, Taiwan.
  • Supparatpinyo K; Department of Internal Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Huang LM; Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.
  • Chiu CH; Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University Col-lege of Medicine, Taoyuan, Taiwan.
  • Chen PY; Department of Pediatrics, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Hwang KP; Division of Pediatric Infectious Diseases, China Medical University College of Medicine, Children's Hospital, Taichung, Taiwan.
  • Danier J; Clinical and Epi Research and Development, GSK, Rockville, Maryland.
  • Friel D; GSK, Wavre, Belgium.
  • Salaun B; Clinical Laboratory Sciences, GSK, Rixensart, Belgium.
  • Woo W; Biostatistics and Statistical Programming Department, GSK, Rockville, Maryland.
  • Vaughn DW; Vaccines Research and Development, GSK, Rockville, Maryland.
  • Innis B; Center for Vaccine Innovation and Access, PATH, Washington, District of Columbia.
  • Schuind A; Vaccine Discovery and Development, GSK, Rockville, Maryland, USA.
Pediatr Infect Dis J ; 40(9): e333-e339, 2021 09 01.
Article em En | MEDLINE | ID: mdl-34285165
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Adjuvantes Imunológicos / Virus da Influenza A Subtipo H5N1 / Imunogenicidade da Vacina / Anticorpos Antivirais Tipo de estudo: Clinical_trials Limite: Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Adjuvantes Imunológicos / Virus da Influenza A Subtipo H5N1 / Imunogenicidade da Vacina / Anticorpos Antivirais Tipo de estudo: Clinical_trials Limite: Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article